CROSSJECT

CROSSJECT

Pre-clinical
Dijon, FranceFounded 1996crossject.com

Crossject is revolutionizing the administration of well-established treatments with its needle-free auto-injector ZENEO®.

Founded
1996
Focus
Drug Delivery

About

Crossject is revolutionizing the administration of well-established treatments with its needle-free auto-injector ZENEO®.

Funding History

2

Total raised: $15.3M

Grant$2.8MEuropean Innovation CouncilNov 15, 2022
Series B$12.5MUndisclosedMay 15, 2021

Company Info

TypePrivate
Founded1996
LocationDijon, France
StagePre-clinical
SIMILAR COMPANIES
4P-Pharma
4P-Pharma
Phase 2 · Lille
Patheon
Patheon
Pre-clinical · Lyon
ABL Diagnostics
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Adjuvatis
Pre-clinical · Lyon
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile